Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Schmidt

Showing results (131-140 of 165) with videos related to

Pageof 17
Sort By:
The Journal of Thoracic and Cardiovascular Surgery|November 7, 1998
Selective anticoagulation with active site-blocked factor IXA suggests separate roles for intrinsic and extrinsic coagulation pathways in cardiopulmonary bypassT B Spanier, J M Chen, M C Oz, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 1994
Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteinsA M Schmidt, M Hasu, D Popov, et al.
The Journal of Clinical Investigation|April 20, 2000
Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic miceE Lalla, I B Lamster, M Feit, et al.
Cancer Treatment Reports|March 1, 1986
Cisplatin and vinblastine chemotherapy for metastatic non-small cell carcinoma followed by irradiation in patients with regional diseaseR H Blum, J Cooper, A M Schmidt, et al.
The American Journal of Pathology|December 1, 1993
Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissuesJ Brett, A M Schmidt, S D Yan, et al.
The Journal of Clinical Investigation|September 1, 1995
Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetesA M Schmidt, O Hori, J X Chen, et al.
Molecular Pharmacology|July 1, 1997
Recombinant advanced glycation end product receptor pharmacokinetics in normal and diabetic ratsC Renard, O Chappey, M P Wautier, et al.
Nature Medicine|June 3, 2000
Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosisS D Yan, H Zhu, A Zhu, et al.
The Journal of Biological Chemistry|October 26, 1999
N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expressionT Kislinger, C Fu, B Huber, et al.
Journal of Medical Primatology|November 21, 2000
Derivation and characterization of a highly pathogenic isolate of human immunodeficiency virus type 2 that causes rapid CD4+ cell depletion in Macaca nemestrinaJ McClure, A M Schmidt, M A Rey-Cuille, et al.
Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
The Journal of Thoracic and Cardiovascular Surgery|November 7, 1998
Selective anticoagulation with active site-blocked factor IXA suggests separate roles for intrinsic and extrinsic coagulation pathways in cardiopulmonary bypassT B Spanier, J M Chen, M C Oz, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 13, 1994
Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteinsA M Schmidt, M Hasu, D Popov, et al.
The Journal of Clinical Investigation|April 20, 2000
Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic miceE Lalla, I B Lamster, M Feit, et al.
Cancer Treatment Reports|March 1, 1986
Cisplatin and vinblastine chemotherapy for metastatic non-small cell carcinoma followed by irradiation in patients with regional diseaseR H Blum, J Cooper, A M Schmidt, et al.
The American Journal of Pathology|December 1, 1993
Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissuesJ Brett, A M Schmidt, S D Yan, et al.
The Journal of Clinical Investigation|September 1, 1995
Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetesA M Schmidt, O Hori, J X Chen, et al.
Molecular Pharmacology|July 1, 1997
Recombinant advanced glycation end product receptor pharmacokinetics in normal and diabetic ratsC Renard, O Chappey, M P Wautier, et al.
Nature Medicine|June 3, 2000
Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosisS D Yan, H Zhu, A Zhu, et al.
The Journal of Biological Chemistry|October 26, 1999
N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expressionT Kislinger, C Fu, B Huber, et al.
Journal of Medical Primatology|November 21, 2000
Derivation and characterization of a highly pathogenic isolate of human immunodeficiency virus type 2 that causes rapid CD4+ cell depletion in Macaca nemestrinaJ McClure, A M Schmidt, M A Rey-Cuille, et al.
Pageof 17